NPs Basic Information

Name
Oleamide
Molecular Formula C18H35NO
IUPAC Name*
(Z)-octadec-9-enamide
SMILES
CCCCCCCC/C=C\CCCCCCCC(=O)N
InChI
InChI=1S/C18H35NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H2,19,20)/b10-9-
InChIKey
FATBGEAMYMYZAF-KTKRTIGZSA-N
Synonyms
Oleamide; 301-02-0; Oleic acid amide; Oleylamide; Oleyl amide; (Z)-octadec-9-enamide; Slip-eze; Adogen 73; (9Z)-octadec-9-enamide; Crodamide O; Armoslip CP; Crodamide OR; cis-9,10-Octadecenoamide; 9-Octadecenamide; 9-Octadecenamide, (9Z)-; (Z)-9-OCTADECENAMIDE; 9-Octadecenamide, (Z)-; cis-9-Octadecenamide; ELAIDOYLAMIDE; 9Z-octadecenamide; Armid O; Unislip 1759; 9,10-octadecenoamide; (9Z)-9-Octadecenamide; Kemamide O; Petrac Slip-Eze; Amide O; 14C-labeled oleamide; Diamide O 200; Tocris-0878; 7L25QK8BWO; CHEMBL15927; CHEBI:116314; NSC-26987; (9E)-OCTADEC-9-ENAMIDE; ELD; 9,10-octadecenamide; octadec-9-enamide; trans-9,10-octadecenoamide; HSDB 5560; 9-Octadecenoic acid, amide (cis); SR-01000597434; EINECS 206-103-9; NSC 26987; UNII-7L25QK8BWO; Oleyramide; Aliphatic amide; AI3-36742; CCRIS 9471; Octadecene amide; MFCD00053638; 9(z)-octadecenamide; (9Z)-octadecenamide; Plastic additive 12; Diamid O 200; Diamit O 200; Oleamide, >=99%; (cis)-9-Octadecenoate; OLEAMIDE [INCI]; 9-Octadecenamide, cis-; cis-9,10-Octadecanamide; DSSTox_CID_7137; (cis)-9-Octadecenoic acid; Octadec-9-enoic acid amide; OLEYL AMIDE [HSDB]; (9Z)-9-Octadecenamide #; DSSTox_RID_78321; DSSTox_GSID_27137; SCHEMBL36321; BSPBio_001489; GTPL284; Oleamide, analytical standard; BML2-C10; DTXSID6027137; BDBM23028; (cis)-9-Octadecenoic acid amide; (Z)-Octadec-9-enoic acid amide; HMS1361K11; HMS1791K11; HMS1989K11; HMS3402K11; HMS3411B12; HMS3649L11; HMS3675B12; HY-N2327; NSC26987; OLEAMIDE (OLEIC ACID AMIDE); ZINC8036015; Tox21_200444; LMFA08010004; AKOS016010402; CCG-208731; PLASTIC ADDITIVE 12 [USP-RS]; IDI1_033959; NCGC00024839-01; NCGC00024839-04; NCGC00024839-05; NCGC00024839-06; NCGC00024839-07; NCGC00024839-08; NCGC00257998-01; AS-12260; CAS-301-02-0; CS-0021046; O0107; Q4370; C19670; A820197; SR-01000597434-1; SR-01000597434-2; W-106956; Plastic additive 20, European Pharmacopoeia (EP) Reference Standard; Plastic additive 12, United States Pharmacopeia (USP) Reference Standard
CAS 301-02-0
PubChem CID 5283387
ChEMBL ID CHEMBL15927
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organic acids and derivat
      • Class: Carboximidic acids and de
        • Subclass: Carboximidic acids
          • Direct Parent: Carboximidic acids

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 281.5 ALogp: 6.6
HBD: 1 HBA: 1
Rotatable Bonds: 15 Lipinski's rule of five: Rejected
Polar Surface Area: 43.1 Aromatic Rings: 0
Heavy Atoms: 20 QED Weighted: 0.303

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.947 MDCK Permeability: 0.00003340
Pgp-inhibitor: 0 Pgp-substrate: 0
Human Intestinal Absorption (HIA): 0.012 20% Bioavailability (F20%): 0.968
30% Bioavailability (F30%): 0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.367 Plasma Protein Binding (PPB): 98.30%
Volume Distribution (VD): 1.665 Fu: 1.03%

ADMET: Metabolism

CYP1A2-inhibitor: 0.304 CYP1A2-substrate: 0.234
CYP2C19-inhibitor: 0.373 CYP2C19-substrate: 0.058
CYP2C9-inhibitor: 0.214 CYP2C9-substrate: 0.906
CYP2D6-inhibitor: 0.162 CYP2D6-substrate: 0.492
CYP3A4-inhibitor: 0.421 CYP3A4-substrate: 0.047

ADMET: Excretion

Clearance (CL): 4.775 Half-life (T1/2): 0.413

ADMET: Toxicity

hERG Blockers: 0.393 Human Hepatotoxicity (H-HT): 0.05
Drug-inuced Liver Injury (DILI): 0.026 AMES Toxicity: 0.02
Rat Oral Acute Toxicity: 0.022 Maximum Recommended Daily Dose: 0.022
Skin Sensitization: 0.947 Carcinogencity: 0.067
Eye Corrosion: 0.029 Eye Irritation: 0.679
Respiratory Toxicity: 0.184
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001646 1.000 D0O1PH 0.757
ENC002845 0.895 D0O1TC 0.538
ENC001555 0.839 D07ILQ 0.519
ENC001699 0.839 D0OR6A 0.468
ENC001419 0.839 D0UE9X 0.462
ENC001100 0.839 D0Z5SM 0.461
ENC001592 0.839 D05ATI 0.444
ENC001591 0.839 D00AOJ 0.393
ENC001710 0.826 D0Z5BC 0.388
ENC001682 0.800 D09SRR 0.375
*Note: the compound similarity was calculated by RDKIT.